在静脉血栓解脱过程中调节巨细胞纤维解质
Tierra A Johnson1, Subhradip Mukhopadhyay2, Marguerite S Buzza3
1Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Thrombosis research
|September 24, 2024
概括
血激素激活剂抑制剂-2型 (PAI-2) 在深静脉血栓症 (DVT) 解决方案中不会直接抑制尿激酶-血激活剂 (uPA). 血原激活剂抑制剂-1型 (PAI-1) 是DVT凝块溶解期间的主要uPA抑制剂.
科学领域:
- 心血管生物学 心血管生物学
- 血栓形成和血液静止.
- 巨细胞生物学 巨细胞生物学
背景情况:
- 静脉血栓塞栓症 (VTE),包括肺栓塞 (PE) 和深静脉血栓症 (DVT),具有显著的死亡率和发病率.
- 静脉血栓的更快解决与患者预后的改善有关.
- 由巨细胞产生的泌尿酸酶-血激素激活剂 (uPA) 对纤维素分解和静脉血栓解决至关重要.
研究的目的:
- 为了研究巨细胞等离子体激活剂抑制剂-2型 (PAI-2) 在抑制UPA介导纤维解 duringDVT解决过程中的作用.
主要方法:
- 使用了一种DVT和分辨率的小鼠模型.
- 在野生型 (WT),PAI-2缺乏和PAI-1缺乏小鼠中进行了纤维素降解的组织学和分子分析.
- 评估了这些基因型的巨细胞的ex vivo纤维解活性.
主要成果:
- PAI-2 缺陷加速了静脉血栓的分离和增加了纤维素降解,反映了 PAI-1 缺陷的影响.
- PAI-2 缺陷并没有改变巨细胞透或 PAI-1 在瘤中的表达.
- 在体内通过巨介导的uPA启动的纤维解质被PAI-1缺乏症增强,但不是PAI-2缺乏症.
结论:
- PAI-2表现出一种独立于巨细胞uPA的间接抗纤维解质活性.
- PAI-1 作为主导的 uPA 抑制剂在 DVT 的解决过程中.
关键词:
纤维素纤维素是一种纤维素.纤维化解是一种纤维化解.巨细胞是一个巨细胞.PAI-1是PAI-1的第一个类型.在PAI-2中,您可以使用PAI-2.塑原激活剂抑制剂抑制剂静脉血栓的形成 静脉血栓的形成更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.7K
06:12Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
Published on: July 21, 2023
563
相关概念视频
01:16Clot Retraction and Fibrinolysis
4.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.4K
01:22Formation of the Platelet Plug
5.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.2K
01:09Coagulation
5.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.5K
01:05Introduction to Hemostasis
6.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.5K